EGFR and cancer: By considering missense mutations (1) directly overlapping phosphosites, (2) proximal to phosphosites, and (3) co-clustering with phosphosites, we noticed that considering co-clustering mutations contribute significantly to the fraction of potentially functional mutations in many cancer genes including EGFR, KRAS, and PIK3CA (Supplementary Fig. 7).